Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
49.76%
↑ 643% vs avg
Percentile
P100
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-9.16%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 49.76% |
| Q2 2025 | -22.62% |
| Q1 2025 | 41.75% |
| Q4 2024 | 43.60% |
| Q3 2024 | -178.22% |
| Q2 2024 | 39.71% |
| Q1 2024 | 19.61% |
| Q4 2023 | 20.00% |
| Q3 2023 | -50.46% |
| Q2 2023 | 35.99% |
| Q1 2023 | -11.30% |
| Q4 2022 | 11.13% |
| Q3 2022 | -53.17% |
| Q2 2022 | 26.49% |
| Q1 2022 | 20.49% |
| Q4 2021 | -6.37% |
| Q3 2021 | 5.61% |
| Q2 2021 | -98.39% |
| Q1 2021 | -109.44% |
| Q4 2020 | 31.95% |
| Q3 2020 | -10.22% |
| Q2 2020 | -16.57% |
| Q1 2020 | 0.00% |